Hoff, Fieke W.; Huang, Ying; Welkie, Rina Li; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Patel, Prapti A.; Collins Jr, Robert H.; Baer, Maria R.; Duong, Vu H.; Blum, William G.; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca L.; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G.; Rosenberg, Leonard; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Yocum, Ashley O.; Borate, Uma M.; Mims, Alice S.; Byrd, John C.; Madanat, Yazan F.

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

接受brexucabtagene autoleucel治疗的复发或难治性B细胞急性淋巴细胞白血病成年患者的三年分析（ZUMA-3）

LEUKEMIA

IF13.4

2025-03-191

OAAI

Shah, Bijal D.; Cassaday, Ryan D.; Park, Jae H.; Houot, Roch; Logan, Aaron C.; Boissel, Nicolas; Leguay, Thibaut; Bishop, Michael R.; Topp, Max S.; O'Dwyer, Kristen M.; Tzachanis, Dimitrios; Arellano, Martha L.; Lin, Yi; Baer, Maria R.; Schiller, Gary J.; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C.; Wierda, William G.; Deangelo, Daniel J.; Stiff, Patrick; Jeyakumar, Deepa; Mao, Daqin; Adhikary, Sabina; Zhou, Lang; Hadjivassileva, Tsveta; Khalid, Rita Damico; Ghobadi, Armin; Oluwole, Olalekan O.

CAR-T-associated Cardiovascular Events are Associated with Increased Resource Utilization

CAR-T相关心血管事件与资源利用增加相关

CIRCULATION

IF38.6

2024-11-120

PRE

IDH2 Mutation Is Associated with Favorable Outcome Among Older Adults with Newly Diagnosed Acute Myeloid Leukemia Treated with Lower-Intensity Therapy

IDH2突变与接受低强度治疗的新诊断急性髓系白血病老年患者的良好预后相关。

BLOOD

IF23.1

2024-11-051

PRE

Hoff, Fieke W.; Huang, Ying; Li Welkie, Rina; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Patel, Prapti A.; Collins, Robert H.; Baer, Maria R.; Duong, Vu H.; Blum, William; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor J.; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja Gullen; Rosenberg, Leonard; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Yocum, Ashley Owen; Borate, Uma; Mims, Alice; Byrd, John C.; Madanat, Yazan F.

Outcomes and Survival in Newly Diagnosed, Older, Acute Myeloid Leukemia Patients from the Beat AML Master Trial in the Venetoclax/Azacitidine Age

新诊断、老年急性髓系白血病患者在Venetoclax/阿扎胞苷时代的Beat AML主试验中的结局与生存情况

BLOOD

IF23.1

2024-11-050

PRE

Borate, Uma; Huang, Ying; Li Welkie, Rina; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Madanat, Yazan F.; Patel, Prapti A.; Collins, Robert H.; Baer, Maria R.; Duong, Vu H.; Blum, William; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor J.; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja Gullen; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Rossenber, Leohard; Yocum, Ashley Owen; Mims, Alice; Byrd, John C.

Effect of Crizanlizumab Infusion during Vaso-Occlusive Crises on Acute Care Utilization for Pain Control

Crizanlizumab输注在血管闭塞性危象期间对疼痛控制急性护理利用的影响

BLOOD

IF23.1

2024-11-050

PRE

Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed NPM1-m or KMT2A-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007

Ziftomenib 与强化诱导 (7+3) 联合治疗新诊断的 NPM1-m 或 KMT2A-r 急性髓系白血病：KOMET-007 研究的期 1a 期中期结果

BLOOD

IF23.1

2024-11-055

PRE

A Randomized Phase 2 Trial of 28-Day (Arm A) Versus 14-Day (Arm B) Schedule of Venetoclax plus Azacitidine in Newly Diagnosed Acute Myeloid Leukemia Patients ≥ 60 Years

一项随机Ⅱ期临床试验，比较28天（A组）与14天（B组）方案下Venetoclax联合Azacitidine治疗初诊急性髓系白血病患者（≥60岁）的效果。

BLOOD

IF23.1

2024-11-050

PRE

Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

Beat-aml 2024 ELN-对新诊断AML的老年人进行低强度治疗的风险分层

BLOOD ADVANCES

IF7.1

2024-10-102

OAAI

Hoff, Fieke W.; Blum, William G.; Huang, Ying; Li Welkie, Rina; Swords, Ronan T.; Traer, Elie; Stein, Eytan M.; Lin, Tara L.; Archer, Kellie J.; Patel, Prapti A.; Collins, Robert H.; Baer, Maria R.; Duong, Vu H.; Arellano, Martha L.; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L.; Kovacsovics, Tibor; Deininger, Michael W.; Zeidner, Joshua F.; Olin, Rebecca L.; Smith, Catherine C.; Foran, James M.; Schiller, Gary J.; Curran, Emily K.; Koenig, Kristin L.; Heerema, Nyla A.; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G.; Rosenberg, Leonard; Druker, Brian J.; Levine, Ross L.; Burd, Amy; Yocum, Ashley O.; Borate, Uma M.; Mims, Alice S.; Byrd, John C.; Madanat, Yazan F.

A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia

BLOOD ADVANCES

IF7.1

2024-05-213

OAAI

Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

每周一次selinexor 40 mg与pomalidomide和地塞米松60 mg在复发和/或难治性多发性骨髓瘤中的疗效和安全性

FRONTIERS IN ONCOLOGY

IF3.3

2024-05-172

OAAI

Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components

减少病原体和常规血小板成分支持的血液病患者的急性肺损伤

BLOOD ADVANCES

IF7.1

2024-05-140

OAAI

Wheeler, Allison P.; Snyder, Edward L.; Refaai, Majed; Cohn, Claudia S.; Poisson, Jessica; Fontaine, Magali; Sehl, Mary; Nooka, Ajay K.; Uhl, Lynne; Spinella, Philip C.; Fenelus, Maly; Liles, Darla; Coyle, Thomas; Becker, Joanne; Jeng, Michael; Gehrie, Eric A.; Spencer, Bryan R.; Young, Pampee; Johnson, Andrew; O'Brien, Jennifer J.; Schiller, Gary J.; Roback, John D.; Malynn, Elizabeth; Jackups, Ronald; Avecilla, Scott T.; Liu, Kathy; Bentow, Stanley; Varrone, Jeanne; Benjamin, Richard J.; Corash, Laurence M.

Gary J. Schiller

个人简介

教育背景

工作经历

荣誉奖项

研究方向